跳至主要内容
临床试验/NCT02295553
NCT02295553已完成4 期

Co-administration of Ketamine and Propofol for Upper Endoscopy in Children: a Dose-finding Study

The Hospital for Sick Children1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
56
试验地点
1
主要终点
Dose of Propofol Required to Prevent Movement (Response) to Insertion of Endoscope Into the Patient's Esophagus

研究概览

简要总结

The purpose of this study is to examine the dose-response relationship of ketamine in combination with propofol.

详细描述

Direct visualization of the esophagus, stomach and small intestine is performed using a scope that is inserted while the patient is under under deep sedation or general anesthesia. The most common method of providing general anesthesia for upper endoscopy is intravenous administration of medications such as propofol, often in combination with other medications such as fentanyl, midazolam, remifentanil or ketamine. One study found that the combination of propofol and ketamine provides better conditions (less patient movement, more stable heart and breathing) but more side effects afterwards compared to propofol and fentanyl.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 3-13 years
  • Receiving general anesthesia for upper endoscopy

排除标准

  • Known or possible difficult airway
  • BMI > 35
  • Weight < 10 kg
  • Sedative premedication required
  • Known contraindication to ketamine or propofol

研究组 & 干预措施

Ketamine 0 mg/kg

Experimental

Ketamine dose will be 0 mg/kg. Propofol dose for the first patient will be 4 mg/kg. Doses for the subsequent patients will increase or decrease by 1.6 mg/kg using the Dixon Up and Down method.

干预措施: Propofol (Drug)

Ketamine 0.25 mg/kg

Experimental

Ketamine dose will be 0.25 mg/kg. Propofol dose for the first patient will be 3 mg/kg. Doses for the subsequent patients will increase or decrease by 1.2 mg/kg using the Dixon Up and Down method.

干预措施: Ketamine (Drug)

Ketamine 0.25 mg/kg

Experimental

Ketamine dose will be 0.25 mg/kg. Propofol dose for the first patient will be 3 mg/kg. Doses for the subsequent patients will increase or decrease by 1.2 mg/kg using the Dixon Up and Down method.

干预措施: Propofol (Drug)

Ketamine 0.5 mg/kg

Experimental

Ketamine dose will be 0.5 mg/kg. Propofol dose for the first patient will be 2.5 mg/kg. Doses for the subsequent patients will increase or decrease by 0.8 mg/kg using the Dixon Up and Down method.

干预措施: Ketamine (Drug)

Ketamine 0.5 mg/kg

Experimental

Ketamine dose will be 0.5 mg/kg. Propofol dose for the first patient will be 2.5 mg/kg. Doses for the subsequent patients will increase or decrease by 0.8 mg/kg using the Dixon Up and Down method.

干预措施: Propofol (Drug)

Ketamine 1.0 mg/kg

Experimental

Ketamine dose will be 1.0 mg/kg. Propofol dose for the first patient will be 2 mg/kg. Doses for the subsequent patients will increase or decrease by 0.4 mg/kg using the Dixon Up and Down method.

干预措施: Ketamine (Drug)

Ketamine 1.0 mg/kg

Experimental

Ketamine dose will be 1.0 mg/kg. Propofol dose for the first patient will be 2 mg/kg. Doses for the subsequent patients will increase or decrease by 0.4 mg/kg using the Dixon Up and Down method.

干预措施: Propofol (Drug)

结局指标

主要结局

Dose of Propofol Required to Prevent Movement (Response) to Insertion of Endoscope Into the Patient's Esophagus

时间窗: This outcome is measured at the time of insertion of the endoscope into the esophagus.

The objective is to determine the effective bolus dose in 50% of subjects (ED50) of propofol in combination with ketamine 0, 0.25, 0.5 and 1 mg/kg that produces an adequate depth of anesthesia to prevent minimal or no movement on endoscope insertion in children

次要结局

  • Duration of Apnea After Propofol Administration(This outcome will be measured after propofol is administered until the end of the procedure.)
  • Incidence of Adverse Respiratory Events During the Procedure(From induction of anesthesia until endoscopy procedure is complete)
  • Incidence of Side Effects and Complications During the Recovery Period(From the time procedure is complete until discharge from hospital with an average time of 1 hour.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jason Hayes

Staff Anaesthesiologist

The Hospital for Sick Children

研究点 (1)

Loading locations...

相似试验